Many of the most devastating infectious diseases are caused by RNA viruses, and Model Medicines is working on one compound to ...

Pfizer is looking to follow its vaccine/oral antiviral combination that has proved so profitable in COVID-19 with a similar approach in respiratory syncytial virus (RSV). The drugmaker is in the ...

At the JPM conference, Pfizer CEO Albert Bourla projected optimism, saying the market was overlooking the pharma company's ...

Also Read: Pfizer's Paxlovid Demonstrates Safety But ... that traditional medical records may overlook. Extended antiviral courses have precedent in other conditions like HIV and hepatitis C ...

Pfizer’s decision to offload $3.05 billion worth of shares in Haleon is a strategic move driven by shifting priorities in a ...

But the report, on the experiences of 13 patients, found that the drug had no benefit for some people and that some who ...

Historically, COVID-19 symptoms have been fevers or chills, cough, shortness of breath, cough, congestion or a runny nose, ...

“Commonly known as the stomach flu, norovirus has been around forever, and has become the leading cause of gastroenteritis or ...

Shares of Pfizer Inc. (NYSE:PFE – Get Free Report) were down 0.2% during trading on Friday . The company traded as low as $26.52 and last traded at $26.57. Approximately 5,717,203 shares changed hands ...

Also Read: Pfizer's Paxlovid Demonstrates Safety But Raises Questions ... sheds light on lived experiences that traditional medical records may overlook. Extended antiviral courses have precedent in ...